Cognitive dysfunction and diabetes mellitus

Endocrine Reviews

Volumn 29, Issue 4, 2008, Pages 494-511

  Kodl, Christopher T ^a   Seaquist, Elizabeth R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BRAIN INJURY; COGNITION; COGNITIVE DEFECT; ELECTROENCEPHALOGRAM; EVOKED RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IN SITU HYBRIDIZATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; POLYNEUROPATHY; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RETINOPATHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STREPTOZOCIN DIABETES; WORKING MEMORY;

ANIMALS; COGNITION; COGNITION DISORDERS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; MODELS, BIOLOGICAL;

EID: 45149104267     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2007-0034     Document Type: Review

References (231)

1. 2003 U.S. Renal Data System (USRDS) Annual Data Report: Atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
2. Miles WR, Root HF 1922 Psychologic tests applied to diabetic patients. Arch Intern Med 30:767-777
3. Brands AM, Kessels RP, Hoogma RP, Henselmans JM, van der Beek Boter JW, Kappelle LJ, de Haan EH, Biessels GJ 2006 Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes 55:1800-1806
4. Ryan CM, Geckle MO, Orchard TJ 2003 Cognitive efficiency declines over time in adults with type 1 diabetes: effects of micro- and macrovascular complications. Diabetologia 46:940-948
5. Ryan CM, Williams TM, Finegold DN, Orchard TJ 1993 Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 36:329-334
6. Wessels AM, Rombouts SA, Remijnse PL, Boom Y, Scheltens P, Barkhof F, Heine RJ, Snoek FJ 2007 Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia 20:1763-1769
7. Weinger K, Jacobson AM, Musen G, Lyoo IK, Ryan CM, Jimerson DC, Renshaw PF 2008 The effects of type 1 diabetes on cerebral white matter. Diabetologia 51:417-425
8. Hershey T, Bhargava N, Sadler M, White NH, Craft S 1999 Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed. Diabetes Care 22:1318-1324
9. Ryan CM 1988 Neurobehavioral complications of type I diabetes. Examination of possible risk factors. Diabetes Care 11:86-93
10. Skenazy JA, Bigler ED 1984 Neuropsychological findings in diabetes mellitus. J Clin Psychol 40:246-258
11. Hershey T, Craft S, Bhargava N, White NH 1997 Memory and insulin dependent diabetes mellitus (IDDM): effects of childhood onset and severe hypoglycemia. J Int Neuropsychol Soc 3:509-520
12. Northam EA, Anderson PJ, Werther GA, Warne GL, Adler RG, Andrewes D 1998 Neuropsychological complications of IDDM in children 2 years after disease onset. Diabetes Care 21:379-384
13. Schoenle EJ, Schoenle D, Molinari L, Largo RH 2002 Impaired intellectual development in children with type I diabetes: association with HbA(1c), age at diagnosis and sex. Diabetologia 45:108-114
14. Northam EA, Anderson PJ, Jacobs R, Hughes M, Warne GL, Werther GA 2001 Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 24:1541-1546
15. Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J 2007 Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356:1842-1852
16. Holmes CS 1986 Neuropsychological profiles in men with insulin-dependent diabetes. J Consult Clin Psychol 54:386-389
17. Kaufman FR, Epport K, Engilman R, Halvorson M 1999 Neurocognitive functioning in children diagnosed with diabetes before age 10 years. J Diabetes Complications 13:31-38
18. Perantie DC, Lim A, Wu J, Weaver P, Warren SL, Hayden T, Christ S, Sadler M, White NH, Hershey T 2007 Severe hypoglycemia vs. hyperglycemia: unique effects on cognition in youth with type 1 diabetes mellitus (TIDM). Diabetes 56(Suppl 1):(Abstract 1887)
19. Cox DJ, Kovatchev BP, Gonder-Frederick LA, Summers KH, McCall A, Grimm KJ, Clarke WL 2005 Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care 28:71-77
20. Rovet J, Alvarez M 1997 Attentional functioning in children and adolescents with IDDM. Diabetes Care 20:803-810
21. Sommerfield AJ, Deary IJ, Frier BM 2004 Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care 27:2335-2340
22. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP 2005 The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28:726-735
23. Ferguson SC, Blane A, Perros P, McCrimmon RJ, Best JJ, Wardlaw J, Deary IJ, Frier BM 2003 Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52:149-156
24. Wessels AM, Rombouts SA, Simsek S, Kuijer JP, Kostense PJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ 2006 Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes 55:334-340
25. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, Cummings SR 2000 Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160:174-180
26. Reaven GM, Thompson LW, Nahum D, Haskins E 1990 Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 13:16-21
27. Munshi M, Grande L, Hayes M, Ayres D, Suhl E, Capelson R, Lin S, Milberg W, Weinger K 2006 Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care 29:1794-1799
28. Perlmuter LC, Hakami MK, Hodgson-Harrington C, Ginsberg J, Katz J, Singer DE, Nathan DM 1984 Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am J Med 77:1043-1048
29. Messier C 2005 Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol Aging 26(Suppl 1):26-30
30. Grodstein F, Chen J, Wilson RS, Manson JE 2001 Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24:1060-1065
31. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K 2004 Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164:1327-1333
32. Mooradian AD, Perryman K, Fitten J, Kavonian GD, Morley JE 1988 Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies. Arch Intern Med 148:2369-2372
33. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A 2001 Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366-370
34. Sinclair AJ, Girling AJ, Bayer AJ 2000 Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract 50:203-212
35. Gregg EW, Brown AM 2003 Cognitive and physical disabilities and aging-related complications of diabetes. Clin Diabetes 21:113-118
36. Bruce DG, Casey GP, Grange V, Clarnette RC, Almeida OP, Foster JK, Ives FJ, Davis TM 2003 Cognitive impairment, physical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetes Study. Diabetes Res Clin Pract 61:59-67
37. Cukierman T, Gerstein HC, Williamson JD 2005 Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 48:2460-2469
38. Curb JD, Rodriguez BL, Abbott RD, Petrovitch H, Ross GW, Masaki KH, Foley D, Blanchette PL, Harris T, Chen R, White LR 1999 Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology 52:971-975
39. Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, Kervinen K, Kesaniemi YA, Riekkinen PJ, Laakso M 1997 Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross-sectional population based study. BMJ 315:1045-1049
40. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ 1997 Risk of dementia among persons with diabetes mellitus: a population-based cohort study. Am J Epidemiol 145:301-308
41. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R 2001 Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154:635-641
42. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM 1996 Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia 39:1392-1397
43. Peila R, Rodriguez BL, Launer LJ 2002 Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 51:1256-1262
44. Sullivan MG, Glycemic control shown to prevent dementia. 10th International Conference on Alzheimer's Disease and Related Disorders, Madrid, Spain, 2006
45. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K, Sueshi K, Tsuneyoshi M, Fujishima M 1995 Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 45:1161-1168
46. Watson GS, Craft S 2003 The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs 17:27-45
47. Yaffe K, Blackwell T, Whitmer RA, Krueger K, Barrett Connor E 2006 Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging 10:293-295
48. Ryan CM, Geckle MO 2000 Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care 23:1486-1493
49. Vanhanen M, Koivisto K, Kuusisto J, Mykkanen L, Helkala EL, Hanninen T, Riekkinen Sr P, Soininen H, Laakso M 1998 Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 21:398-402
50. de Vegt F, Dekker JM, Ruhe HG, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ 1999 Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926-931
51. Dilley J, Ganesan A, Deepa R, Deepa M, Sharada G, Williams OD, Mohan V 2007 Association of A1C with cardiovascular disease and metabolic syndrome in Asian Indians with normal glucose tolerance. Diabetes Care 30:1527-1532
52. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N 2004 Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141:413-420
53. Kumari M, Marmot M 2005 Diabetes and cognitive function in a middle-aged cohort: findings from the Whitehall II study. Neurology 65:1597-1603
54. Scott RD, Kritz-Silverstein D, Barrett-Connor E, Wiederholt WC 1998 The association of non-insulin-dependent diabetes mellitus and cognitive function in an older cohort. J Am Geriatr Soc 46:1217-1222
55. Lindeman RD, Romero LJ, LaRue A, Yau CL, Schade DS, Koehler KM, Baumgartner RN, Garry PJ 2001 A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: the New Mexico Elder Health Survey. Diabetes Care 24:1567-1572
56. 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 329:977-986
57. 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837-853
58. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B 2005 Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653
59. Austin EJ, Deary IJ 1999 Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care 22:1273-1277
60. Sommerfield AJ, Deary IJ, McAulay V, Frier BM 2003 Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetes. Diabetes Care 26:390-396
61. Widom B, Simonson DC 1990 Glycemic control and neuropsychologic function during hypoglycemia in patients with insulindependent diabetes mellitus. Ann Intern Med 112:904-912
62. Warren RE, Zammitt NN, Deary IJ, Frier BM 2007 The effects of acute hypoglycaemia on memory acquisition and recall and prospective memory in type 1 diabetes. Diabetologia 50:178-185
63. Maran A, Lomas J, Macdonald IA, Amiel SA 1995 Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia 38:1412-1418
64. Deary IJ, Crawford JR, Hepburn DA, Langan SJ, Blackmore LM, Frier BM 1993 Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 42:341-344
65. Howorka K, Pumprla J, Saletu B, Anderer P, Krieger M, Schabmann A 2000 Decrease of vigilance assessed by EEG-mapping in type I diabetic patients with history of recurrent severe hypoglycaemia. Psychoneuroendocrinology 25:85-105
66. Wredling R, Levander S, Adamson U, Lins PE 1990 Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia 33:152-157
67. Kodl C, Franc D, Anderson FS, Lim KO, Seaquist ER, Diffusion tensor imaging (DTI) identifies defects in white matter microstructure in subjects with diabetes. American Diabetes Association 67th Scientific Session, Chicago, IL, 2007
68. DCCT Research Group 1996 Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 124:379-388
69. Chabriat H, Sachon C, Levasseur M, Grimaldi A, Pappata S, Rougemont D, Masure MC, De Recondo A, Samson Y 1994 Brain metabolism after recurrent insulin induced hypoglycaemic episodes: a PET study. J Neurol Neurosurg Psychiatry 57:1360-1365
70. Perros P, Deary IJ, Sellar RJ, Best JJ, Frier BM 1997 Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20:1013-1018
71. Reichard P, Britz A, Rosenqvist U 1991 Intensified conventional insulin treatment and neuropsychological impairment. BMJ 303:1439-1442
72. Ack M, Miller I, Weil Jr WB 1961 Intelligence of children with diabetes mellitus. Pediatrics 28:764-770
73. Ryan C, Vega A, Drash A 1985 Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 75:921-927
74. Ryan CM 1997 Effects of diabetes mellitus on neuropsychological functioning: a lifespan perspective. Semin Clin Neuropsychiatry 2:4-14
75. Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH 2002 Ageing and diabetes: implications for brain function. Eur J Pharmacol 441:1-14
76. Brownlee M 2005 The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625
77. Klein JP, Waxman SG 2003 The brain in diabetes: molecular changes in neurons and their implications for end-organ damage. Lancet Neurol 2:548-554
78. Toth C, Schmidt AM, Tuor UI, Francis G, Foniok T, Brussee V, Kaur J, Yan SF, Martinez JA, Barber PA, Buchan A, Zochodne DW 2006 Diabetes, leukoencephalopathy and rage. Neurobiol Dis 23:445-461
79. Sredy J, Sawicki DR, Notvest RR 1991 Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy. J Diabet Complications 5:42-47
80. Malone JI, Hanna SK, Liang X, Saporta S, Park CR, Diamond D 2007 Diabetes increases polyol pathway activity in the brain which is blocked by sorbinil. Diabetes 56(Suppl 1) (Abstract 793)
81. Yan SD, Stern D, Schmidt AM 1997 What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose. Eur J Clin Invest 27:179-181
82. Girones X, Guimera A, Cruz-Sanchez CZ, Ortega A, Sasaki N, Makita Z, Lafuente JV, Kalaria R, Cruz-Sanchez FF 2004 N ε-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease. Free Radic Biol Med 36:1241-1247
83. Heitner J, Dickson D 1997 Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49:1306-1311
84. Niiya Y, Abumiya T, Shichinohe H, Kuroda S, Kikuchi S, Ieko M, Yamagishi S, Takeuchi M, Sato T, Iwasaki Y 2006 Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species. Brain Res 1108:179-187
85. Zimmerman GA, Meistrell 3rd M, Bloom O, Cockroft KM, Bianchi M, Risucci D, Broome J, Farmer P, Cerami A, Vlassara H, Tracey KJ 1995 Neurotoxicity of advanced glycation endproducts during focal stroke and neuroprotective effects of aminoguanidine. Proc Natl Acad Sci USA 92:3744-3748
86. Ramakrishnan R, Sheeladevi R, Suthanthirarajan N 2004 PKC-α mediated alterations of indoleamine contents in diabetic rat brain. Brain Res Bull 64:189-194
87. Sieber FE, Hurn P, Alkayed NJ, Traystman RJ 2001 Gender-based differences in Na+ -K+ adenosine triphosphatase activity occur in the microcirculation of the diabetic rat brain. Anesthesiology 94:372-375
88. Castellani RJ, Siedlak SL, Fortino AE, Perry G, Ghetti B, Smith MA2005 Chitin-like polysaccharides in Alzheimer's disease brains. Curr Alzheimer Res 2:419-423
89. Aragno M, Mastrocola R, Medana C, Restivo F, Catalano MG, Pons N, Danni O, Boccuzzi G 2005 Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment. Endocrinology 146:5561-5567
90. Kamal A, Biessels GJ, Urban IJ, Gispen WH 1999 Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience 90:737-745
91. Welsh B, Wecker L 1991 Effects of streptozotocin-induced diabetes on acetylcholine metabolism in rat brain. Neurochem Res 16:453-460
92. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH 1994 Cerebral function in diabetes mellitus. Diabetologia 37:643-650
93. McCall AL 1992 The impact of diabetes on the CNS. Diabetes 41:557-570
94. Reske-Nielsen E, Lundbaek K 1965 Pathological changes in the central and peripheral nervous system of young long-term diabetics. I. Diabetic encephalopathy. Diabetologia 1:233-241
95. Reske-Nielsen E, Lundbaek K 1968 Pathological changes in the central and peripheral nervous system of young long-term diabetics. II. The spinal cord and peripheral nerves. Diabetologia 4:34-43
96. Johnson PC, Brendel K, Meezan E 1982 Thickened cerebral cortical capillary basement membranes in diabetics. Arch Pathol Lab Med 106:214-217
97. Rodriguez G, Nobili F, Celestino MA, Francione S, Gulli G, Hassan K, Marenco S, Rosadini G, Cordera R 1993 Regional cerebral blood flow and cerebrovascular reactivity in IDDM. Diabetes Care 16:462-468
98. Duckrow RB, Beard DC, Brennan RW 1987 Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke 18:52-58
99. Kushner M, Nencini P, Reivich M, Rango M, Jamieson D, Fazekas F, Zimmerman R, Chawluk J, Alavi A, Alves W 1990 Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome. Ann Neurol 28:129-135
100. Li PA, Shuaib A, Miyashita H, He QP, Siesjo BK, Warner DS 2000 Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. Stroke 31:183-192
101. Coyle JT, Puttfarcken P 1993 Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695
102. Sima AA, Li ZG 2005 The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes 54:1497-1505
103. Lognig BM, Kromeke O, Optenhostert-Porstt C, Wolf OT 2005 Hippocampal volume and cognitive performance in long-standing type 1 diabetic patients without macrovascular complications. Diabet Med 23:32-39
104. Patrick AW, Campbell IW 1990 Fatal hypoglycaemia in insulin-treated diabetes mellitus: clinical features and neuropathological changes. Diabet Med 7:349-354
105. Auer RN 2004 Hypoglycemic brain damage. Metab Brain Dis 19:169-175
106. Auer RN 2004 Hypoglycemic brain damage. Forensic Sci Int 146:105-110
107. Elusiyan JB, Adeodu OO, Adejuyigbe EA 2006 Evaluating the validity of a bedside method of detecting hypoglycemia in children. Pediatr Emerg Care 22:488-490
108. Comi G 1997 Evoked potentials in diabetes mellitus. Clin Neurosci 4:374-379
109. Siesjo BK, Bengtsson F 1989 Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J Cereb Blood Flow Metab 9:127-140
110. Wieloch T 1985 Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 230:681-683
111. Jauch-Chara K, Hallschmid M, Gais S, Schmid SM, Oltmanns KM, Colmorgen C, Born J, Schultes B 2007 Hypoglycemia during sleep impairs consolidation of declarative memory in type 1 diabetic and healthy humans. Diabetes Care 30:2040-2045
112. Bendtson I, Gade J, Theilgaard A, Binder C 1992 Cognitive function in type 1 (insulin-dependent) diabetic patients after nocturnal hypoglycaemia. Diabetologia 35:898-903
113. Matyka KA, Wigg L, Pramming S, Stores G, Dunger DB 1999 Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes. Arch Dis Child 81:138-142
114. Marks JL, Porte Jr D, Stahl WL, Baskin DG 1990 Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 127:3234-3236
115. Unger J, McNeill TH, Moxley 3rd RT, White M, Moss A, Livingston JN 1989 Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 31:143-157
116. Brant AM, Jess TJ, Milligan G, Brown CM, Gould GW 1993 Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system. Biochem Biophys Res Commun 192:1297-1302
117. Ibberson M, Uldry M, Thorens B 2000 GLUTX1, a novel mammalian glucose transporter expressed in the central nervous system and insulin-sensitive tissues. J Biol Chem 275:4607-4612
118. Carayannopoulos MO, Chi MM, Cui Y, Pingsterhaus JM, McKnight RA, Mueckler M, Devaskar SU, Moley KH 2000 GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst. Proc Natl Acad Sci USA 97:7313-7318
119. Reagan LP, Gorovits N, Hoskin EK, Alves SE, Katz EB, Grillo CA, Piroli GG, McEwen BS, Charron MJ 2001 Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats. Proc Natl Acad Sci USA 98:2820-2825
120. Seaquist ER, Damberg GS, Tkac I, Gruetter R 2001 The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes 50:2203-2209
121. Hasselbalch SG, Knudsen GM, Videbaek C, Pinborg LH, Schmidt JF, Holm S, Paulson OB 1999 No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans. Diabetes 48:1915-1921
122. Namba H, Lucignani G, Nehlig A, Patlak C, Pettigrew K, Kennedy C, Sokoloff L 1987 Effects of insulin on hexose transport across blood-brain barrier in normoglycemia. Am J Physiol 252:E299-E303
123. Bingham EM, Hopkins D, Smith D, Pernet A, Hallett W, Reed L, Marsden PK, Amiel SA 2002 The role of insulin in human brain glucose metabolism: an 18-fluoro-deoxyglucose positron emission tomography study. Diabetes 51:3384-3390
124. Anthony K, Reed LJ, Dunn JT, Bingham E, Hopkins D, Marsden PK, Amiel SA 2006 Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome? Diabetes 55:2986-2992
125. 1994 Diagnostic and statistical manual of mental disorders (DSM-IV). Washington, DC: American Psychiatric Association
126. Ferini-Strambi L, Smirne S, Garancini P, Pinto P, Franceschi M 1990 Clinical and epidemiological aspects of Alzheimer's disease with presenile onset: a case control study. Neuroepidemiology 9:39-49
127. Landin K, Blennow K, Wallin A, Gottfries CG 1993 Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder? J Intern Med 233:357-363
128. Nielson KA, Nolan JH, Berchtold NC, Sandman CA, Mulnard RA, Cotman CW 1996 Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease? J Am Geriatr Soc 44:897-904
129. Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC 2004 Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53:474-481
130. Bucht G, Adolfsson R, Lithner F, Winblad B 1983 Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand 213:387-392
131. Fujisawa Y, Sasaki K, Akiyama K 1991 Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type. Biol Psychiatry 30:1219-1228
132. Hoyer S 1998 Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 105:415-422
133. Frolich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Turk A, Hoyer S, Zochling R, Boissl KW, Jellinger K, Riederer P 1998 Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 105:423-438
134. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte Jr D 1998 Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50:164-168
135. Wenk GL 2006 Neuropathologic changes in Alzheimer's disease: potential targets for treatment. J Clin Psychiatry 67(Suppl 3):3-7; quiz, 23
136. Stone WS, Cottrill KL, Walker DL, Gold PE 1988 Blood glucose and brain function: interactions with CNS cholinergic systems. Behav Neural Biol 50:325-334
137. Stone WS, Croul CE, Gold PE 1988 Attenuation of scopolamine-induced amnesia in mice. Psychopharmacology (Berl) 96:417-420
138. Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y, Luby J, Dagogo-Jack A, Alderson A 1996 Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging 17:123-130
139. Craft S, Dagogo-Jack SE, Wiethop BV, Murphy C, Nevins RT, Fleischman S, Rice V, Newcomer JW, Cryer PE 1993 Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behav Neurosci 107:926-940
140. Reger MA, Watson GS, Frey 2nd WH, Baker LD, Cholerton B, Keeling ML, Belongia DA, Fishel MA, Plymate SR, Schellenberg GD, Cherrier MM, Craft S 2006 Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol Aging 27:451-458
141. Skeberdis VA, Lan J, Zheng X, Zukin RS, Bennett MV 2001 Insulin promotes rapid delivery of N-methyl-D- aspartate receptors to the cell surface by exocytosis. Proc Natl Acad Sci USA 98:3561-3566
142. Palovcik RA, Phillips MI, Kappy MS, Raizada MK 1984 Insulin inhibits pyramidal neurons in hippocampal slices. Brain Res 309:187-191
143. Mirzaei S, Gelpi E, Booij J, Rodrigues M, Neumann I, Zaknun J, Koehn H, Knoll P 2004 New approaches in nuclear medicine for early diagnosis of Alzheimer's disease. Curr Alzheimer Res 1:219-229
144. Mosconi L, De Santi S, Li Y, Li J, Zhan J, Tsui WH, Boppana M, Pupi A, de Leon MJ 2006 Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET. Eur J Nucl Med Mol Imaging 33:210-221
145. von Borczyskowski D, Wilke F, Martin B, Brenner W, Clausen M, Mester J, Buchert R 2006 Evaluation of a new expert system for fully automated detection of the Alzheimer's dementia pattern in FDG PET. Nucl Med Commun 27:739-743
146. Kalaria RN, Harik SI 1989 Abnormalities of the glucose transporter at the blood-brain barrier and in brain in Alzheimer's disease. Prog Clin Biol Res 317:415-421
147. Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P 1994 Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann Neurol 35:546-551
148. Benedict L, Nelson CA, Schunk E, Sullwold K, Seaquist ER 2006 Effect of insulin on the brain activity obtained during visual and memory tasks in healthy human subjects. Neuroendocrinology 83:20-26
149. Craft S, Asthana S, Schellenberg G, Cherrier M, Baker LD, Newcomer J, Plymate S, Latendresse S, Petrova A, Raskind M, Peskind E, Lofgreen C, Grimwood K 1999 Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender. Neuroendocrinology 70:146-152
150. Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL 2001 Improving influence of insulin on cognitive functions in humans. Neuroendocrinology 74:270-280
151. Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm HL, Born J, Kern W 2004 Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29:1326-1334
152. Craft S, Asthana S, Cook DG, Baker LD, Cherrier M, Purganan K, Wait C, Petrova A, Latendresse S, Watson GS, Newcomer JW, Schellenberg GD, Krohn AJ 2003 Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology 28:809-822
153. Lockette W, Kirkland K, Farrow S 1996 α2-Adrenergic agonists increase cellular lactate efflux. Hypertension 27:1104-1107
154. Holloway R, Zhou Z, Harvey HB, Levasseur JE, Rice AC, Sun D, Hamm RJ, Bullock MR 2007 Effect of lactate therapy upon cognitive deficits after traumatic brain injury in the rat. Acta Neurochir (Wien) 149:919 -927; discussion, 927
155. Maran A, Crepaldi C, Trupiani S, Lucca T, Jori E, Macdonald IA, Tiengo A, Avogaro A, Del Prato S 2000 Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and type I diabetic subjects. Diabetologia 43:733-741
156. Kalman J, Palotas A, Bodi N, Kincses TZ, Benedek G, Janka Z, Antal A 2005 Lactate infusion fails to improve semantic categorization in Alzheimer's disease. Brain Res Bull 65:533-539
157. Hak AE, Pols HA, Stehouwer CD, Meijer J, Kiliaan AJ, Hofman A, Breteler MM, Witteman JC 2001 Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in non-diabetic elderly: the Rotterdam study. J Clin Endocrinol Metab 86:4398-4405
158. Hull M, Strauss S, Berger M, Volk B, Bauer J 1996 The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Behav Brain Res 78:37-41
159. Rosler N, Wichart I, Jellinger KA 2001 Intra vitam lumbar and post mortem ventricular cerebrospinal fluid immunoreactive interleukin-6 in Alzheimer's disease patients. Acta Neurol Scand 103:126-130
160. Tojo C, Takao T, Nishioka T, Numata Y, Suemaru S, Hashimoto K 1996 Hypothalamic-pituitary-adrenal axis in WBN/Kob rats with non-insulin dependent diabetes mellitus. Endocr J 43:233-239
161. Lee ZS, Chan JC, Yeung VT, Chow CC, Lau MS, Ko GT, Li JK, Cockram CS, Critchley JA 1999 Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients. Diabetes Care 22:1450-1457
162. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME 1994 Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 14:2047-2053
163. de Quervain DJ, Roozendaal B, Nitsch RM, McGaugh JL, Hock C 2000 Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nat Neurosci 3:313-314
164. Newcomer JW, Selke G, Melson AK, Hershey T, Craft S, Richards K, Alderson AL 1999 Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 56:527-533
165. Lupien S, Lecours AR, Lussier I, Schwartz G, Nair NP, Meaney MJ 1994 Basal cortisol levels and cognitive deficits in human aging. J Neurosci 14:2893-2903
166. Forget H, Lacroix A, Somma M, Cohen H 2000 Cognitive decline in patients with Cushing's syndrome. J Int Neuropsychol Soc 6:20-29
167. Brunetti A, Fulham MJ, Aloj L, De Souza B, Nieman L, Oldfield EH, Di ChiroG1998 Decreased brain glucose utilization in patients with Cushing's disease. J Nucl Med 39:786-790
168. Brown ES, Rush AJ, McEwen BS 1999 Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology 21:474-484
169. Gould E, Tanapat P 1999 Stress and hippocampal neurogenesis. Biol Psychiatry 46:1472-1479
170. Joels M, de Kloet ER 1989 Effects of glucocorticoids and norepinephrine on the excitability in the hippocampus. Science 245:1502-1505
171. Pavlides C, McEwen BS 1999 Effects of mineralocorticoid and glucocorticoid receptors on long-term potentiation in the CA3 hippocampal field. Brain Res 851:204-214
172. Sapolsky RM, Uno H, Rebert CS, Finch CE 1990 Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 10:2897-2902
173. Braak H, Braak E 1997 Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351-357
174. Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K 1985 Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4:2757-2763
175. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K 1985 Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249
176. Goedert M 1987 Neuronal localization of amyloid β protein precursor mRNA in normal human brain and in Alzheimer's disease. EMBO J 6:3627-3632
177. Sinha S, Lieberburg I 1999 Cellular mechanisms of β-amyloid production and secretion. Proc Natl Acad Sci USA 96:11049-11053
178. Gasparini L, Gouras GK, Wang R, Gross RS, Beal MF, Greengard P, Xu H 2001 Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 21:2561-2570
179. Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, Rosner MR, Selkoe DJ 2000 Neurons regulate extracellular levels of amyloid β-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20:1657-1665
180. Sasaki N, Toki S, Chowei H, Saito T, Nakano N, Hayashi Y, Takeuchi M, Makita Z 2001 Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res 888:256-262
181. Craft S, Asthana S, Schellenberg G, Baker L, Cherrier M, Boyt AA, Martins RN, Raskind M, Peskind E, Plymate S 2000 Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann NY Acad Sci 903:222-228
182. Zhao L, Teter B, Morihara T, Lim GP, Ambegaokar SS, Ubeda OJ, Frautschy SA, Cole GM 2004 Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention. J Neurosci 24:11120-11126
183. Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield JP, Haroutunian V, Buxbaum JD, Xu H, Greengard P, Relkin NR 2000 Intraneuronal Aβ42 accumulation in human brain. Am J Pathol 156:15-20
184. LaFerla FM, Green KN, Oddo S 2007 Intracellular amyloid-β in Alzheimer's disease. Nat Rev Neurosci 8:499-509
185. Mochizuki A, Tamaoka A, Shimohata A, Komatsuzaki Y, Shoji S 2000 Aβ42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease. Lancet 355:42-43
186. Westermark P, Wilander E 1978 The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15:417-421
187. Schwartz P 1965 Senile cerebral, pancreatic insular and cardiac amyloidosis. Trans NY Acad Sci 27:393-413
188. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB 1987 Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 84:8628-8632
189. Lorenzo A, Razzaboni B, Weir GC, Yankner BA 1994 Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368:756-760
190. Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, Kimura H 1995 Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci USA 92:1989-1993
191. Craig EA, Weissman JS, Horwich AL 1994 Heat shock proteins and molecular chaperones: mediators of protein conformation and turnover in the cell. Cell 78:365-372
192. Li ZG, Zhang W, Sima AA 2007 Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56:1817-1824
193. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA 1993 Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923
194. Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, Craft S 2005 Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 13:950-958
195. Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA, Roses AD 2006 Efficacy of rosiglitazone in a genetically defined population with mild-tomoderate Alzheimer's disease. Pharmacogenomics J 6:246-254
196. Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR 2006 Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol 199:265-273
197. Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, O'Banion K, Klockgether T, Van Leuven F, Landreth GE 2005 Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice. Brain 128:1442-1453
198. Landreth G 2006 PPARγ agonists as new therapeutic agents for the treatment of Alzheimer's disease. Exp Neurol 199:245-248
199. Inestrosa NC, Godoy JA, Quintanilla RA, Koenig CS, Bronfman M 2005 Peroxisome proliferator-activated receptor γ is expressed in hippocampal neurons and its activation prevents β-amyloid neurodegeneration: role of Wnt signaling. Exp Cell Res 304:91-104
200. Camacho IE, Serneels L, Spittaels K, Merchiers P, Dominguez D, De Strooper B 2004 Peroxisome-proliferator-activated receptor γ induces a clearance mechanism for the amyloid-β peptide. J Neurosci 24:10908-10917
201. d'Abramo C, Ricciarelli R, Pronzato MA, Davies P 2006 Troglitazone, a peroxisome proliferator-activated receptor-γ agonist, decreases tau phosphorylation in CHOtau4R cells. J Neurochem 98:1068-1077
202. Lago RM, Singh PP, Nesto RW 2007 Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet 370:1129-1136
203. Nissen SE, Wolski K 2007 Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356:2457-2471
204. Ryan CM 1999 Memory and metabolic control in children. Diabetes Care 22:1239-1241
205. Williams AD 2001 Psychometric concerns in neuropsychological testing. Neuro Rehabilitation 16:221-224
206. Walsh P, Kane N, Butler S 2005 The clinical role of evoked potentials. J Neurol Neurosurg Psychiatry 76(Suppl 2):ii16 -ii22
207. Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH 1991 Evidence for diabetic encephalopathy. Diabet Med 8:162-167
208. Martini A, Comacchio F, Fedele D, Crepaldi G, Sala O 1987 Auditory brainstem evoked responses in the clinical evaluation and follow-up of insulin-dependent diabetic subjects. Acta Otolaryngol 103:620-627
209. Parving A, Elberling C, Balle V, Parbo J, Dejgaard A, Parving HH 1990 Hearing disorders in patients with insulin-dependent diabetes mellitus. Audiology 29:113-121
210. Kurita A, Katayama K, Mochio S 1996 Neurophysiological evidence for altered higher brain functions in NIDDM. Diabetes Care 19:360-364
211. Gupta PR, Dorfman LJ 1981 Spinal somatosensory conduction in diabetes. Neurology 31:841-845
212. Pozzessere G, Rizzo PA, Valle E, Mollica MA, Meccia A, Morano S, Di Mario U, Andreani D, Morocutti C 1988 Early detection of neurological involvement in IDDM and NIDDM. Multimodal evoked potentials versus metabolic control. Diabetes Care 11:473-480
213. Lobmann R, Smid HG, Pottag G, Wagner K, Heinze HJ, Lehnert H 2000 Impairment and recovery of elementary cognitive function induced by hypoglycemia in type-1 diabetic patients and healthy controls. J Clin Endocrinol Metab 85:2758-2766
214. Amiel SA, Pottinger RC, Archibald HR, Chusney G, Cunnah DT, Prior PF, Gale EA 1991 Effect of antecedent glucose control on cerebral function during hypoglycemia. Diabetes Care 14:109-118
215. Haumont D, Dorchy H, Pelc S 1979 EEG abnormalities in diabetic children: influence of hypoglycemia and vascular complications. Clin Pediatr (Phila) 18:750-753
216. Akisaki T, Sakurai T, Takata T, Umegaki H, Araki A, Mizuno S, Tanaka S, Ohashi Y, Iguchi A, Yokono K, Ito H 2006 Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 22:376-384
217. Yousem DM, Tasman WS, Grossman RI 1991 Proliferative retinopathy: absence of white matter lesions at MR imaging. Radiology 179:229-230
218. Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, Biessels GJ 2006 Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55:1106-1113
219. den Heijer T, Vermeer SE, van Dijk EJ, Prins ND, Koudstaal PJ, Hofman A, Breteler MM 2003 Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46:1604-1610
220. Ferguson SC, Blane A, Wardlaw J, Frier BM, Perros P, McCrimmon RJ, Deary IJ 2005 Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 28:1431-1437
221. Musen G, Lyoo IK, Sparks CR, Weinger K, Hwang J, Ryan CM, Jimerson DC, Hennen J, Renshaw PF, Jacobson AM 2006 Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55:326-333
222. Wessels AM, Simsek S, Remijnse PL, Veltman DJ, Biessels GJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ, Rombouts SA 2006 Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49:2474-2480
223. Perantie DC, Wu J, Koller JM, Lim A, Warren SL, Black KJ, Sadler M, White NH, Hershey T 2007 Voxel-based morthometry detects brain volume changes due to hypo- and hyperglycemia in youth with type 1 diabetes mellitus (TIDM). Diabetes 56(Suppl 1) (Abstract 1886)
224. Rosenthal JM, Amiel SA, Yaguez L, Bullmore E, Hopkins D, Evans M, Pernet A, Reid H, Giampietro V, Andrew CM, Suckling J, Simmons A, Williams SC 2001 The effect of acute hypoglycemia on brain function and activation: a functional magnetic resonance imaging study. Diabetes 50:1618-1626
225. Musen G, Bolo N, Jacobson A, Southwick A 2007 Brain functional correlates of gray matter changes in type 1 diabetes. Diabetes 56(Suppl 1) (Abstract 792)
226. Niwa H, Koumoto C, Shiga T, Takeuchi J, Mishima S, Segawa T, Atsumi T, Shimizu C, Koike T, Yoshioka N 2006 Clinical analysis of cognitive function in diabetic patients by MMSE and SPECT. Diabetes Res Clin Pract 72:142-147
227. Keymeulen B, de Metz K, Cluydts R, Bossuyt A, Somers G 1996 Technetium-99m hexamethylpropylene amine oxime singlephoton emission tomography of regional cerebral blood flow in insulin-dependent diabetes. Eur J Nucl Med 23:163-168
228. Sabri O, Hellwig D, Schreckenberger M, Schneider R, Kaiser HJ, Wagenknecht G, Mull M, Buell U 2000 Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow. Nucl Med Commun 21:19-29
229. Lim KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP 2002 Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry 51:890-895
230. Wozniak JR, Mueller BA, Chang PN, Muetzel RL, Caros L, Lim KO 2006 Diffusion tensor imaging in children with fetal alcohol spectrum disorders. Alcohol Clin Exp Res 30:1799-1806
231. Wu J, Perantie DC, Sadler M, White NH, Hershey T 2007 Pilot diffusion tensor imaging study in youth with type 1 diabetes mellitus reveals change in white matter integrity associated with chronic hyperglycemia. Diabetes 56(Suppl 1) (Abstract 1889)